January 30, 2025 - 19:39

Columbus Public Health has confirmed a case of tuberculosis at Whitehall-Yearling High School, prompting immediate action from health officials. The agency is actively collaborating with the school district to implement contact tracing measures to identify and notify individuals who may have been exposed to the disease.
Health officials emphasize the importance of early detection and treatment to prevent further spread of tuberculosis. They are working diligently to ensure that all necessary precautions are taken to safeguard the health of students and staff. The school community is being urged to remain vigilant and report any symptoms related to tuberculosis, which can include persistent cough, fever, and unexplained weight loss.
As the situation develops, Columbus Public Health is committed to providing updates and resources to the community. Parents and guardians are encouraged to stay informed and participate in any health screenings or informational sessions organized by the school and health officials. The priority remains the health and safety of all students as the investigation continues.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...